ABC Arbitrage’s Esperion Therapeutics ESPR Stock Holding History

ABC Arbitrage’s Portfolio ESPR Stock Details ESPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-42,553	Closed	-$134K	–	436
2026 Q2	$134K	Buy	+42,553	New	+$119K	0.01%	312

ABC Arbitrage's ESPR Position: Q3 2026 in Review

ABC Arbitrage sold out of Esperion Therapeutics (ESPR) in Q3 2026, closing a stake of 42,553 shares — an estimated $134K sold.

ABC Arbitrage first reported a position in ESPR in Q2 2026 and held it in 1 quarter. The position peaked at $134K in Q2 2026. 1 fund tracked by Wall St. Rank holds ESPR as of Q3 2026.

ABC Arbitrage reported no remaining Esperion Therapeutics position as of Q3 2026 after selling out during the quarter.
ABC Arbitrage sold 42,553 Esperion Therapeutics shares in Q3 2026, an estimated $134K.
ABC Arbitrage first reported a position in Esperion Therapeutics in Q2 2026 and held it in 1 quarter.
ABC Arbitrage's Esperion Therapeutics position peaked at $134K in Q2 2026.
1 fund tracked by Wall St. Rank held Esperion Therapeutics as of Q3 2026.

Based on ABC Arbitrage's 13F filing for Q3 2026, filed 23 Oct 2026.